African Early Phase Clinical Research Network

One coordinated network for early-phase research across Africa.

AE-PCRN links research institutions across African countries into a single, inspection-ready front door for Phase I and early-phase trials, so sponsors and funders can run the next decade of vaccine and infectious-disease research where it matters most.

10
Countries
22
Member institutions
50+
Scientific leaders
$0
Fees · dues · exclusivity
One front door
A single contract and coordinating team across every market, not dozens of separate deals.
Inspection-ready
Quality aligned to FDA, ICH and WHO, built in from the first visit.
Built in-country
Investigators, coordinators and monitors based where the work happens.
Ready to activate
Pre-qualified sites move straight to execution, not assessment.
The Platform

The constraint is not capability, it is coordination.

Capable institutions across Africa have long worked in isolation, qualified country by country, contract by contract. AE-PCRN connects them into one platform with shared standards, shared governance, and a single point of entry for sponsors and funders.

The network

Research institutions, investigators, laboratories, depots and manufacturing across ten country hubs.

Preparedness

Standing outbreak capacity, ready before it is needed.

For sponsors

One partner, every market, with inspection-ready quality.

Members

A portal for institutions to profile capability and see opportunities.

Membership

Join a platform, not just a network.

Institutions register to profile their capability, connect with sponsors and funders, and access member-only opportunities and resources.

No membership fees, no annual dues, no general exclusivity, and no obligation to join any study. Every member keeps full operational, scientific and contractual independence, and the coordinating center takes no share of any member institution's study budget.